Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia
Open Access
- 30 September 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Obesity is common comorbidity in patients with schizophrenia. Previous studies have reported that homocysteine (Hcy) is increased in schizophrenia. However, no study has reported the association between BMI and Hcy levels in schizophrenia. This cross-sectional naturalistic study aimed to evaluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic schizophrenia. Clinical and anthropometric data as well as plasma Hcy level and glycolipid parameters were collected. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Our results showed that compared with the low BMI group, the high BMI group had a higher PANSS general psychopathology subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cholesterol (all p < 0.05). Hcy levels were negatively associated with BMI in patients (p < 0.001). Hcy level, the PANSS general psychopathology subscale, total cholesterol and education (all p < 0.05) were the influencing factors of high BMI. Our study suggest that Hcy level may be associated with BMI in patients with schizophrenia. Moreover, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels.Keywords
This publication has 61 references indexed in Scilit:
- Changes in Body Composition Predict Homocysteine Changes and Hyperhomocysteinemia in KoreaJournal of Korean Medical Science, 2013
- The Development of Neural Synchrony and Large-Scale Cortical Networks During Adolescence: Relevance for the Pathophysiology of Schizophrenia and Neurodevelopmental HypothesisSchizophrenia Bulletin, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injuryRenal Failure, 2010
- The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts.European Journal of Endocrinology, 2008
- Homocysteine-Reducing Strategies Improve Symptoms in Chronic Schizophrenic Patients with HyperhomocysteinemiaBiological Psychiatry, 2006
- Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychoticJournal of Psychopharmacology, 2005
- Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysisMolecular Psychiatry, 2005
- Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damageJournal of Neuroscience Research, 2002
- Cerebral and cerebellar haemangioblastoma occurring in the same patientThe Italian Journal of Neurological Sciences, 1983